| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.9M | +745.1% |
| Cost of Revenue | $10.3M | +636.5% |
| Gross Profit | $1.6M | — |
| R&D Expense | $8K | — |
| Operating Income | -$12.8M | +27.2% |
| Pre-tax Income | -$195.3M | -853.5% |
| Net Income | -$195.0M | -852.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.8M | +274.2% |
| Accounts Receivable | $1.3M | — |
| Inventory | $1.1M | +196.6% |
| Current Assets | $10.2M | +366.5% |
| Total Assets | $11.6M | +384.4% |
| Current Liabilities | $38.4M | +457.4% |
| Total Liabilities | $39.3M | +431.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | -251.5% |
| Capital Expenditures | $117K | +151.7% |
| Investing Cash Flow | -$117K | -107.4% |
| Financing Cash Flow | $11.4M | +466.9% |
| Free Cash Flow | -$6.5M | -249.0% |
| Stockholders' Equity |
| -$27.5M |
| -449.0% |